Biomarkers of Bad Biology: Curse or a Blessing? (Q90420263)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30539488 AND SRC:MED&resulttype=core&format=json

13 April 2020

editorial

0 references

title

Biomarkers of Bad Biology: Curse or a Blessing? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30539488 AND SRC:MED&resulttype=core&format=json

13 April 2020

1 reference

Sudeep Banerjee

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30539488 AND SRC:MED&resulttype=core&format=json

13 April 2020

Jason K Sicklick

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30539488 AND SRC:MED&resulttype=core&format=json

13 April 2020

publication date

11 December 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30539488 AND SRC:MED&resulttype=core&format=json

Annals of Surgical Oncology

13 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30539488 AND SRC:MED&resulttype=core&format=json

13 April 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30539488 AND SRC:MED&resulttype=core&format=json

13 April 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30539488 AND SRC:MED&resulttype=core&format=json

13 April 2020

page(s)

318-320

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30539488 AND SRC:MED&resulttype=core&format=json

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

13 April 2020

cites work

1 reference

12 December 2020

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

1 reference

12 December 2020

Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer

1 reference

12 December 2020

O6-methylguanine-DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas: results from the CCG-945 Cohort

1 reference

12 December 2020

Overexpression of cysteine dioxygenase reduces intracellular cysteine and glutathione pools in HepG2/C3A cells

1 reference

12 December 2020

Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial

1 reference

12 December 2020

Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer.

1 reference

12 December 2020

Frequent inactivation of cysteine dioxygenase type 1 contributes to survival of breast cancer cells and resistance to anthracyclines.

1 reference

12 December 2020

Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

1 reference

12 December 2020

Cysteine catabolism: a novel metabolic pathway contributing to glioblastoma growth

1 reference

12 December 2020

Recurrent epimutation of SDHC in gastrointestinal stromal tumors

1 reference

12 December 2020

Promoter Methylation of CDO1 Identifies Clear-Cell Renal Cell Cancer Patients with Poor Survival Outcome

1 reference

12 December 2020

Prognostic Significance of Promoter DNA Hypermethylation of cysteine dioxygenase 1 (CDO1) Gene in Primary Breast Cancer

1 reference

12 December 2020

CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer

1 reference

12 December 2020

Promoter DNA methylation of CDO1 gene and its clinical significance in esophageal squamous cell carcinoma.

1 reference

12 December 2020

CDO1 promoter methylation is associated with gene silencing and is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients

1 reference

12 December 2020

11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial

1 reference

12 December 2020

PARP inhibitors: Synthetic lethality in the clinic

1 reference

12 December 2020

Adjuvant Chemotherapy for Stage II Colon Cancer: A Clinical Dilemma

1 reference

12 December 2020

Prognostic significance of promoter DNA hypermethylation of the cysteine dioxygenase 1 (CDO1) gene in primary gallbladder cancer and gallbladder disease.

1 reference

12 December 2020

Cysteine dioxygenase type 1 (CDO1) gene promoter methylation during the adenoma-carcinoma sequence in colorectal cancer.

1 reference

12 December 2020

Epigenetic Status of CDO1 Gene May Reflect Chemosensitivity in Colon Cancer with Postoperative Adjuvant Chemotherapy

1 reference

12 December 2020

10.1245/S10434-018-07105-W

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30539488 AND SRC:MED&resulttype=core&format=json

13 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30539488 AND SRC:MED&resulttype=core&format=json

13 April 2020

PubMed publication ID

30539488

1 reference